Page last updated: 2024-08-22

clodronic acid and Peritoneal Carcinomatosis

clodronic acid has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kane, AB; Miselis, NR; Van Rooijen, N; Wu, ZJ	1

Other Studies

1 other study(ies) available for clodronic acid and Peritoneal Carcinomatosis

Article	Year
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Molecular cancer therapeutics, 2008, Volume: 7, Issue:4 Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cell Proliferation; Clodronic Acid; Cytokines; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Injections, Intraperitoneal; Liposomes; Macrophages; Mesothelioma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Invasiveness; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2008

Article

Year

Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:4

Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cell Proliferation; Clodronic Acid; Cytokines; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Injections, Intraperitoneal; Liposomes; Macrophages; Mesothelioma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Invasiveness; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2008